Abstract Details

Title Piribedil Efficacy in Monotherapy (150 to 300mg/day) in De Novo Parkinsonian Patients: A 6-Month Analysis of the 2-Year Parkinson-Regain Study

Topic

Presentation(s)

Poster/Presentation
Number 096

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Gobinathan Devathasan, MD, FAAN	No disclosure on file
	No disclosure on file
Bhavesh Trikamji, MD (University of California Los Angeles)	Dr. Trikamji has nothing to disclose.
	No disclosure on file